Introduction
Protein transport through the secretory pathway occurs via transport vesicles under the direction of a large set of protein components (1) . The process can be divided into three stages: (a) vesicle budding, (b) vesicle docking, and (c) membrane fusion, with distinct sets of proteins mediating each stage. The budding stage involves recruitment of coat proteins to the membrane and culminates with the release of coated vesicles (2) . Vesicular transport between membrane compartments requires high specificity and tight regulation to deliver cargo molecules in donor vesicles to the correct acceptor organelle and thereby maintain the integrity of distinct compartments. To ensure the proper directionality of membrane flow, the target organelle must possess appropriate molecular machinery allowing for specific recognition and docking of the incoming vesicle. The docking reaction is likely to require a set of integral membrane proteins on the vesicle and target membranes, termed SNAREs.
Initially, the SNARE proteins were thought to confer specificity through their pair-wise interactions (3) . However, more recent evidence suggests that SNAREs cannot be the only targeting components: some SNAREs can function at several transport steps in vivo (4) , SNAREs that faithfully function at different transport steps in vivo can interact promiscuously in vitro, and some SNAREs have been found in multiple SNARE complexes (5) . Likewise, members of the Rab GTPase family were at first thought to be the principle determinants for targeting specificity because distinct family members display unique organellar localizations that correlate with their site of action (6) . However, it has been demonstrated that a single chimeric Rab protein can function at two transport steps (7) , indicating that the Rabs cannot be the sole determinants for specificity in vesicle docking.
Given that neither Rabs nor SNAREs are the sole determinants of targeting specificity, other components must play important roles. Additional candidate include the so-called tethering factors, which are proteins that link donor and acceptor vesicle membranes prior to together, these results indicate that specificity in vesicle docking and fusion might be generated by the interaction of several factors in such a way that no individual component plays the dominant role.
A recent genetic screen identified temperature-sensitive alleles of two yeast genes, SEC34 and SEC35, that, when incubated at the restrictive temperature, are defective in ER to Golgi transport and accumulate large numbers of 50-nm vesicles (10) . Mutant alleles of these genes can be efficiently suppressed by YPT1, which encodes the Rab GTPase required early in the secretory pathway, or by SLY1-20, which encodes a dominant form of the ER to Golgi SNARE-associated protein Sly1p. Weaker suppression is evident upon overexpression of genes encoding the v-SNAREs SEC22, BET1, or YKT6, a trait shared with all previously characterized ER to Golgi tethering factors (11) (12, 13) . Based on these data, it was hypothesized that SEC34 and SEC35 might be involved in tethering. This was demonstrated to be the case for SEC34 and SEC35 by the discovery that these genes displayed a genetic interaction with genes involved in tethering and that both Sec34p and Sec35p are required in an in vitro tethering assay (12, 13) . Using a cell-free assay that measures distinct steps in vesicle transport from the ER to the Golgi, it was shown that Sec34p and Sec35p are required for a vesicle docking stage catalyzed by the tethering factor Uso1p (12) . These genetic and biochemical results suggest Sec34p and Sec35p may act with Uso1p to dock ER-derived vesicles to the Golgi.
Sec34p is a peripheral membrane protein with a calculated molecular weight of 93 kD.
Fractionation of yeast cytosol indicates that Sec34p and Sec35p exist in an ~450-kD protein complex (13, 14) . Recently Sec34p has also been described as Grd20p, a protein involved in the proper localization of yeast enzymes to the trans-Golgi network (TGN) (15) . A severe defect in TGN localization of Kex2p and missorting of vacuolar carboxypeptidase Y occurs rapidly after loss of Grd20p function. A complete loss of GRD20 function also results in a severe growth defect although the growth defect appears to be independent of the TGN sorting defect. The Grd20/Sec34 protein is only partially localized to the TGN so it is possible that the observed Golgi localization defects of Kex2p are indirect and a manifestation of defects in Golgi recycling. Alternatively, Sec34p might be a general transport factor that is involved in several membrane trafficking steps. Additional experiments will be required to unambiguously address these possibilities.
In this study, we report the cloning and sequencing of a novel membrane-associated human protein, p94. Based on several independent lines of evidence, we propose that p94 is hSec34, the human orthologue of yeast Sec34p. p94 has sequence and structural homology to the yeast vesicle tethering factor Sec34p, it localizes to the cis-Golgi, and like yeast Sec34p, it exists as a component of high molecular complex. Although yeast Sec34p is predicted to act on the same transport step as Uso1p, the localization of hSec34p and its sensitivity to Brefeldin A differ from that of p115, a human orthologue of Uso1p. Therefore we propose that hSec34 may function on the vesicle transport step that is distinct from the one that requires p115. 
Experimental Procedures
Cloning of hSec34p -The sequence encoding the amino-terminal part of the hSec34 was amplified from a human colon cDNA library (Marathon -Ready TM cDNA, Clontech) using the Marathon adaptor primer (5'primer: ccatcctaatacgactcactatagggcc) and an internal hSEC34 specific primer (3' primer: gtaactgacttgtgagggtctgtagtgtg). The polymerase chain reaction was carried out using high fidelity Pfu Turbo TM polymerase from Stratagene (La Jolla, CA).
The resulting 850bp DNA fragment was cloned into pBluscript vector digested with NotI and SmaI.
The SEC34 ORF was cloned from a human fetal brain cDNA library using a 2-stage Rapid-Screen TM system (OriGene Technologies Inc., Rockville,MD). The cDNA library was screened by PCR according to the manufacturer's recomendations using HSEC34 gene specific primers (5' primer: gcttccaattgaagacttgtgc and 3' primer: gcaaagctttagaaagacactg ).
The resulting positive clone in the vector pCMV6-XL4 contained a 4.5kb hSec34 cDNA (pCMV-hSec34).
Plasmid construction -To construct a His 6 fusion to the amino-terminus of hSec34p (pHis 6 ∆hSec34), a 843 bp fragment of hSec34 was amplified by PCR creating a BamHI site adjacent to the codon for the first amino acid of hSec34 (5' primer: caggatccatggcggaggcggcgctgttg) and an internal hSEC34 specific primer (gtaactgacttgtgagggtctgtagtgtg). The PCR-product was cloned into the pTOPO vector using a Zero Blunt Generation of anti-hSec34p antibody -A 247 amino acid protein that corresponding to hSec34p amino acid sequences from 35 to 281 was expressed in bacteria and purified by nickel chelate column chromatography. The purified protein was used to immunize rabbits and specific antibodies were affinity purified from the serum on nitrocellulose strips containing electroblotted His 6 ∆hSec34 protien.
Northern analysis -Northern blot analyses were performed using human polyA The strongest homology between the yeast and human proteins is found in a region containing amino acid residues 174 to 280 (32% identity and 54% similarity) and in a region containing amino acid residues 554 to 626 (34% identity and 52% similarity), indicating that the functional elements of the protein could reside in these regions. These regions are also highly conserved in potential homologues of Sec34 found in the Drosophila melanogaster genome data base (AAF51107) and the genomes of Schisosaccharomyces pombe Table 1 . We also have found that the carboxyl terminal half (amino acid residues 301-807) of hSec34p is similar (21% identical and 40% similar) to the central domain (amino acid residues 610-1106) of the endosomal tethering factor EEA1 (data not shown).
Northern blot analysis for HSEC34 revealed a transcript of about 4.5 kilobases in length that is abundantly and ubiquitously expressed in all tissues examined with the highest RNA level observed in pancreas and testis and the lowest level found in lung (Fig.2a) . By contrast the level of a control transcript (β-actin) was more abundant in lung than in pancreas and testis. Ubiquitous expression is indeed a feature expected of an essential molecule like Sec34. Therefore we conclude that the cDNA isolated from the fetal brain library represents a full-length hSec34 RNA molecule.
The sequence encoding amino-terminal part of hSec34p was used to develop proteinspecific rabbit polyclonal antibodies. Affinity-purified anti-hSec34p antibodies recognize a To determine if soluble hSec34p exists in a high molecular weight complex, membranes and cytosols were fractionated on glycerol velocity gradients (Figure 3d , C-cytosol, Mmembrane). In HeLa cytosols, hSec34p migrated as a 300kDa species, indicated that it is part of a protein complex (Figure 3d) . In HeLa membranes, hSec34p was found in even larger protein complex(es), that may indicate associations with cognate t-SNARE membrane receptors. These observations for hSec34p are consistent with those for yeast Sec34p which is also associated with a high molecular weight protein complex (13, 14) . (Figure 4a, lower row) . We also used a pharmacological approach to explore the colocalization of hSec34p and membrin. Nocodazole treatment induces microtubule depolymerization that leads to fragmentation and dispersal of the Golgi (23) . Figure 4b shows that after nocodazole treatment YFP-hSec34 was localized on the same Golgi fragments as was CFP-membrin (lower row). Thus, in three different situations, hSec34p is localized to the same cis/medial-Golgi compartment as is membrin.
We used CFP-hSec34 to confirm that our CFP, GFP and YFP fusion proteins had biochemical properties consistent with those we have defined for endogenous hSec34p.
CFP-hSec34 expressed in CV-1 cells (Figure 3b ) and in HeLa cells (data not shown) was found in both cytoplasmic and membrane fractions similar to endogenous hSec34p. CFPhSec34 was also efficiently incorporated into high molecular weight (~300kDa) complexes as defined by glycerol velocity gradients in both soluble (Figure 3d 
GFP-VSVG moves though hSec34p-positive compartment.
To provide more direct evidence that hSec34p localized to the cis-face of Golgi apparatus, we used the temperature-sensitive vesicular stomatitis virus G protein, tsO45 VSVG that transits the secretory pathway (24) .
HeLa cells were co-transfected with pCFP-hSec34 and a plasmid encoding tsO45 VSVG fused with GFP (GFP-VSVG) (25) . In cells expressing GFP-VSVG at 39. 
GFP-hSec34p localization is distinct from the localization of p115 and TGN38.
The vesicle tethering factor p115 is predominantly associated with vesicular-tubular clusters (VTCs) adjacent to the Golgi stack (27) , and cycles extensively between the Golgi and the earlier compartments of the secretory pathway (28) . A yeast homologue of p115, Uso1p has been characterized and shown to function in the same step of the secretory pathway as does Sec34p in tethering ER-derived vesicles to cis-Golgi cisternae (11, 13, 29) . Secretory membrane trafficking in mammalian cells has more morphologically distinct steps compared to the yeast secretory pathway (for instance, yeast do not have morphologically identifiable VTCs) and it was therefore important to compare localization of hSec34 and p115. Yeast Sec34p has been partially co-localized with trans-Golgi marker proteins (15) . We have tested if hSec34p is co-localized with either human p115 (30, 31) or the trans-Golgi marker TGN38 (32, 33) . In HeLa and CV-1 cells, GFP-hSec34 was generally localized in what appear to be the same juxtanuclear membranes as p115 and TGN38 (Figure 6 ), but the GFP-hSec34 signal only partially overlapped with p115 and TGN38 in both untreated and nocodazole-treated cells. Interestingly, after a short treatment with nocodazole (30-60 min), GFP-hSec34 bearing Golgi fragments were completely separated from TGN38-positive membranes (data not shown). The distinctive localization of GFP-Sec34 on the p115 and TGN38-negative membranes was even more evident when the Golgi complex was analyzed by confocal microscopy (Figure 6b) . Thus, GFP-Sec34 is either localized to distinct Golgi membrane domains devoid of p115 and TGN38 or there is intermingling of distinct hSec34p positive and p115 and TGN38 positive Golgi vesicles in the juxtanuclear compartment.
hSec34p association to Golgi membranes is sensitive to Brefeldin A. Treatment of cultured cells with fungal metabolite brefeldin A (BfA) induces the formation of extensive membrane tubules from the Golgi apparatus, trans-Golgi network, and early endosomes in a microtubule-dependent manner (34) . This is thought to be due to BfA's inhibition of nucleotide exchange onto ADP-ribosylation factor (ARF), a low-molecular weight GTP binding protein (35) that prevents assembly of cytosolic coat proteins (including COP I components) onto target membranes. At the same time, extensive retrograde transport of Golgi components to the ER mediated by growth of Golgi tubules occurs in the presence of BfA, leading to a complete loss of Golgi structure (22) . After a 30 min BfA treatment, normally Golgi resident proteins are detected in a characteristic ER pattern, whereas COPII components and tethering factor p115 are found in punctate structures scattered throughout the cell (28, 36) . In cells treated with BfA, GFP-hSec34 (Figure 7a,c) , as well as the endogenous hSec34p (Figure 7b ), were displaced from the Golgi cisternae to the cytosol.
After of incubation with BfA for 30 min a ~7 -fold increase in soluble hSec34 was observed (Figure 7b) . The diffuse distribution of hSec34 after BfA treatment was distinct from that of p115 that was found in punctate structures (Figure 7c) . In cells first pretreated with Nocodazole and then incubated with BfA (Figure 7a , lower row), GFP-hSec34 was displaced from the Golgi fragments to the cytosol with kinetics similar to that of control cells.
hSec34 associated with static Golgi cisternae and excluded from transport vesicles.
Having established that hSec34p is primarily associated with the cis/medial Golgi apparatus, we sought to determine if hSec34 was also present on ER-derived or intra-Golgi vesicles. In yeast cells, Sec34p acts in the tethering of ER-derived vesicles to cis-Golgi. In an in vitro trafficking assay, acceptor (Golgi) membranes prepared from sec34-2 mutant cells were found to be defective (13) . The t-SNARE protein Sed5p has also been shown to operate in the same compartment (37) . Therefore, we compared the localization of YFP-hSec34 and the t-SNARE CFP-Syntaxin5 in time lapse studies of HeLa cells (Figure 8a ). Both molecules were largely localized in the juxtanuclear region, but whereas CFP-Syntaxin5 was also found on rapidly moving vesicular structures (Figure 8a , left column) probably representing anterograde and intra-Golgi vesicles (18) , YFP-hSec34 remained localized to relatively static Golgi cisternae (Figure 8a, left column) . The GFP-hSec34 was not associated with the β-COP-positive vesicular structures (data not shown). A similar situation was observed when HeLa cells were co-transfected with plasmids encoding YFP-hSec34 and GFP-hSec13. As reported previously (38) , GFP-hSec13 was localized to small cytoplasmic vesicles distributed throughout the cytoplasm but most concentrated in a juxtanuclear region (Figure 8b, right panel) . By contrast, YFP-hSec34 was exclusively found on the juxtanuclear Golgi stacks (Figure 8b, left panel) .
Discussion
In this study, we report the cloning and characterization of a novel membrane-associated human protein, p94. Based on three independent lines of evidence, we propose that the ubiquitously expressed p94 is the orthologue of the yeast Golgi tethering factor Sec34p. p94 has sequence and structural homology to Sec34p; it partially localizes to membraness, it is found in high molecular weight complexes; and it localizes morphologically to the cis/medial-Golgi cisternae. We have therefore named this new protein hSec34p. complex (VL and ES, unpublished observations). Interestingly, mammalian database searches using the human Sec34p sequence revealed that the carboxyl-terminal two-thirds of the protein (amino acid residues 301 to 810) is 40% similar to the early endosomal tethering factor EEA1. EEA1 has been shown to physically interact with rab5 and the endosomal t-SNARE syntaxin 6 (39, 40) . In the yeast cell, Sec34p and the Rab protein Ypt1p play a role in tethering ER-derived vesicles to the cis-Golgi (13). Thus, it is possible that the evolutionary conserved domains in Sec34p may function to connect Rab proteins and SNAREs to facilitate vesicle tethering to the cis-Golgi in all eukaryotic cells.
We have determined that hSec34p is a peripheral membrane protein localized to the cis/medial cisternae of Golgi apparatus. On these membranes it colocalizes with the cisGolgi operating v-SNARE membrin and its t-SNARE partner syntaxin 5. Unlike the SNAREs, which are present on both the relatively static Golgi cisternae and on rapidly moving transport vesicles (18) , hSec34p only localizes to the Golgi cisternae, a feature that is in good agreement with a proposed role for hSec34p as component of vesicle tethering machinery.
Characterization of the soluble and membrane-bound pools of hSec34p on glycerol velocity gradients demonstrate that the protein is a part of a high molecular weight complex(es). Similarly, yeast Sec34p behaves as a component of a high molecular weight complex when soluble proteins are separated on gel filtration columns (13, 14) and on glycerol velocity gradients (our unpublished observation). In this complex, yeast Sec34p is stably associated with another tethering protein Sec35p (12) (13) (14) . However, searches of GenBank did not reveal any human Sec35p homologues. Nearly half of Sec35p is predicted to form a coil-coil structure (12) In Saccharomyces cerevisiae, SEC34 genetically interacts with another vesicle tethering factor USO1 (11, 13, 29) . Uso1p in yeast is clearly involved in movement of anterograde ER-derived vesicles to Golgi apparatus (11, 13, 29) and full-length Uso1 protein is required for the assembly of functional ER-Golgi SNARE complexes (11, 13, 29) . The phenotype of sec34 mutants is more complex. Besides the ER to Golgi trafficking defects (11, 13, 29) , sec34/grd20 mutants mislocalize several Golgi-resident proteins and underglycosylate the secretory enzyme invertase (11, 13, 29) . This feature was previously observed for mutant vti1, a v-SNARE involved in the retrograde intra-Golgi trafficking (11, 13, 29) . In addition, Sec34p physically interacts with the sub-set of yeast SNARE proteins involved in retrograde trafficking (our unpublished observations).
The mammalian orthologue of Uso1p, p115, participates in the assembly and maintenance of normal Golgi structure and is required for ER to Golgi vesicle trafficking at a pre-Golgi stage (41, 42) . We find that p115 is only partially co-localized with hSec34p on Golgi cisternae and on scattered Golgi fragments in cells treated with nocodazole. Although both proteins appear to be localized on the same membrane elements, they are apparently preferentially enriched in different membrane sub-domains. As is the case in yeast, it is possible that in mammalian cells both p115 and the hSec34 protein complex are regulating different sides of cis-Golgi-oriented membrane trafficking. In this model, p115 would tether anterograde ER-derived vesicles while the hSec34p complex would regulate proper targeting of retrograde intra-Golgi vesicles. Additional experiments using in vitro transport assays and the cloned hSec34 we have characterized will be required to test this model. between cytosolic and membrane fractions, HeLa and CV-1 (wild type and transfected with pGFP-hSec34) cells were grown to 50% confluency collected in PBS, and lysed by vortexing with glass beads. Cytosol and membrane fractions were separated centrifugation at 150,000 xg using a Beckman TLA55 rotor. The volumes for both fractions were adjusted and equivalent proportions of each fraction analyzed by SDS-PAGE and immunoblotting using anti-hSec34p. C. To determine is hSec34p is enriched in Golgi fractions, rat liver Golgi membranes were isolated from a light mitochondrial fraction on a discontinuous sucrose gradient (43) . The total liver lysate (total) and Golgi membranes (Golgi) (20µg of protein each) were separated on 12% gels, and immunoblotted using affinity purified anti- B.
